4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline

We are 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline CAS:183322-18-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
CAS.NO:183322-18-1
Synonyms:6,7-bis(2-methoxy-ethoxy)-4-chloroquinazoline
Molecular Formula:C14H17ClN2O4
Molecular Weight:312.74900
 
Physical and Chemical Properties:
Density:1.257
Melting point:105-107ºC
Boiling point:446.7ºC
Flash point:224ºC
Index of Refraction:1.561
 
Specification:
Appearance:White powder
Purity:≥99.0%
Melting point:106-108ºC
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Erlotinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline


Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.76-83-5 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.2- (3- (3 – ((7-cloroquinolin-2-il) (tiofen-2-il) metil) fenil) -3-oxopropil) benzoato de metilo CAS:133791-17-0 Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.Methyl 2-bromo-2-methylpropionate Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.

Related Products
Product Name
N-[3-(methylamino)propyl]oxolane-2-carboxamide View Details
BPC 157 View Details
(4S)-4-benzyl-1,3-oxazolidine-2,5-dione View Details
1-chloro-8-iodooctane manufacturer 2-Amino-4,6-dichloropyrimidine manufacturer 4-Guanidinobenzoic acid hydrochloride manufacturer N-(tert-Butoxycarbonyl)sulfamide manufacturer Bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate manufacturer